Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2022-09-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司使用暂时闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the use of temporarily idle raised funds by Shanghai MicroPort EP MedTech Co., Ltd. for cash management. It references regulatory guidelines, the amount and purpose of raised funds, investment projects, risk control measures, and approvals by the board and supervisory committee. The document is not a full financial report but a regulatory compliance and verification statement related to the use of raised funds. It does not contain financial statements or earnings data. The document length is 4168 characters, which is relatively short and focused on a specific regulatory compliance matter. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2022-09-28 Chinese
关于相关股东延长股份锁定期的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Shanghai MicroPort EP MedTech Co., Ltd. regarding the extension of the lock-up period for shares held by major shareholders and certain directors and senior management. It details the lock-up commitments, conditions triggering the extension (such as stock price falling below the IPO price for 20 consecutive trading days), and confirms that the lock-up extension is in compliance with regulatory requirements. The document does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory announcement about shareholding restrictions and lock-up period extensions, not a financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-09-28 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司以募集资金置换已预先投入募投项目及已支付发行费用之自筹资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities regarding the use of raised funds by Shanghai MicroPort EP MedTech Co., Ltd. to replace self-raised funds previously invested in projects and issuance expenses. It references regulatory guidelines, approval from the China Securities Regulatory Commission, and includes detailed financial figures about the fundraising and fund usage. The document includes audit opinions, board and supervisory committee approvals, and a verification report from an accounting firm. It is not a full annual or interim report but a specialized audit/verification report related to the use of raised funds. The document length is 4015 characters, which is substantial and contains detailed financial and procedural information, not just an announcement or certification. Therefore, it fits best under Audit Report / Information (AR), as it is a standalone audit/verification report concerning the use of funds raised in an IPO and compliance with regulatory requirements. FY 2022
2022-09-28 Chinese
微电生理公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Shanghai MicroPort EP MedTech Co., Ltd. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, and other governance matters. It references relevant laws and regulations, and includes chapters on the general provisions, business scope, shares, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting, profit distribution, auditing, notices, mergers, amendments to the articles, litigation, arbitration, and appendices. The content is a comprehensive governance document that sets out the internal rules and structure of the company rather than a financial report or announcement. It is not an annual report, audit report, earnings release, or any other financial or capital market filing. It is clearly a governance document describing the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the full governance document, not just an announcement or summary.
2022-08-29 Chinese
微电生理首次公开发行股票科创板上市公告书
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市公告书" which translates to "Listing Announcement" or "IPO Listing Announcement" for Shanghai MicroPort EP MedTech Co., Ltd. It discusses the company's initial public offering (IPO) on the Shanghai Stock Exchange STAR Market (科创板). The content includes detailed risk disclosures, product pipeline, market competition, financial performance, and other information relevant to the IPO process. It is not a financial report like an annual or quarterly report, nor is it a regulatory filing or a simple announcement of a report. It is a comprehensive document related to the company's stock listing and IPO process. This type of document fits best under the category of Capital/Financing Update (CAP), as it relates to the company's capital raising and listing on the stock exchange.
2022-08-29 Chinese
微电生理首次公开发行股票并在科创板上市招股说明书
Regulatory Filings Classification · 95% confidence The document is a detailed prospectus for an initial public offering (IPO) on the Shanghai Stock Exchange's STAR Market (科创板). It includes extensive information about the company's business, risks, product pipeline, market competition, financial data, and governance. The document is titled as a 招股说明书, which translates to "Prospectus" or "Offering Document". This type of document is typically filed as part of the IPO process and is not an annual report, earnings release, or other routine financial report. It is not a simple announcement or certification but a comprehensive disclosure document for investors. Given the detailed nature and length (15,000 characters), and the focus on the IPO and listing, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and filings that do not fit other categories, including IPO prospectuses and offering documents.
2022-08-24 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.